Respiratory syncytial virus (RSV) vaccine - RSV vaccine for older adults
Background
Respiratory syncytial virus (RSV) is a common cause of respiratory tract infections. For most adults, RSV causes a mild illness, such as a cough or cold, and usually gets better on its own.
In a small number of older adults, RSV infection can lead to serious health problems. People with lung disease or a weakened immune system are more at risk. It can cause pneumonia (infection of the lungs) and, in some cases, death. RSV may also make symptoms of existing heart and lung conditions worse.
Most RSV infections occur in autumn and winter, but you can have the RSV vaccine at any time of the year.
Fact: Recent research shows that the RSV vaccine can lower the chance of being admitted to hospital. In people aged 75 to 79 years, it reduces this risk by around 75%.
The RSV vaccine is safe. It meets all safety standards. Once a vaccine is in use, its safety continues to be monitored.
Help protect yourself against serious illness from RSV by having the RSV vaccine when it is offered to you.
Eligibility for the vaccine
About the vaccine
Safety and effectiveness
More information
- RSV – Vaccine Knowledge Project (external site)
- World Health Organization – Respiratory syncytial virus (RSV) (external site)
- Healthcare products Regulatory Agency (MHRA) Respiratory Syncytial Virus (RSV) Vaccine Factsheet – Information for Patients, Parents and Carers (external site)
Page last reviewed: 1st September 2026